We are live on ! Find out more
HLA

Hamilton Lane Advisors Portfolio holdings

AUM $149M
1-Year Est. Return 14.17%
This Fund
S&P 500
This Quarter Est. Return
-17.2%
1 Year Est. Return
-14.17%
3 Year Est. Return
+186.76%
5 Year Est. Return
+98.42%
10 Year Est. Return
+778.69%
AUM
$152M
AUM Growth
-$47M
Cap. Flow
-$19.6M
Cap. Flow %
-12.89%
Top 10 Hldgs %
57.36%
Holding
79
New
18
Increased
8
Reduced
22
Closed
16

Top Sells

Rank Stock Value
1
ZAYO
Zayo Group Holdings, Inc.
ZAYO
+$8.1M
2
CDW icon
CDW
CDW
+$4.23M
3
HUBS icon
HubSpot
HUBS
+$3.6M
4
RRC icon
Range Resources
RRC
+$3.1M
5
AR icon
Antero Resources
AR
+$2.59M

Sector Composition

Rank Sector Weight
1 Technology 40.35%
2 Communication Services 22.53%
3 Healthcare 8.1%
4 Consumer Discretionary 6.22%
5 Financials 5.32%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TWOU
51
DELISTED
2U Inc
TWOU
$313K 0.21%
+346
New +$352K
AGRX
52
DELISTED
Agile Therapeutics
AGRX
$308K 0.2%
27
-1
-4% -$14K
AIMT
53
DELISTED
Aimmune Therapeutics
AIMT
$302K 0.2%
+14,773
New +$302K
MYOK
54
DELISTED
MyoKardia, Inc. Common Stock
MYOK
$283K 0.19%
+21,854
New +$337K
CHRS icon
55
Coherus Oncology
CHRS
$221M
$265K 0.17%
9,399
DATA
56
DELISTED
Tableau Software, Inc.
DATA
$260K 0.17%
6,157
HAPN
57
Happen Inc
HAPN
$2.24B
$216K 0.14%
+8,218
New +$226K
GBT
58
DELISTED
Global Blood Therapeutics, Inc.
GBT
$211K 0.14%
+14,628
New +$257K
MCRB icon
59
Seres Therapeutics
MCRB
$45.2M
$147K 0.1%
744
CEMP
60
DELISTED
Cempra, Inc.
CEMP
$75K 0.05%
+26,653
New +$323K
GRPN icon
61
Groupon
GRPN
$1.06B
$59K 0.04%
891
-10,358
-92% -$871K
TLPH icon
62
Talphera
TLPH
$71.6M
$32K 0.02%
+624
New +$38.4K
TOVX icon
63
Theriva Biologics
TOVX
$9.44M
$18K 0.01%
3
AGIO icon
64
Agios Pharmaceuticals
AGIO
$1.91B
-19,280
Closed -$1.02M
CDW icon
65
CDW
CDW
$18.6B
-92,568
Closed -$4.23M
GOOG icon
66
Alphabet (Google) Class C
GOOG
$4.27T
-48,280
Closed -$1.88M
QTWO icon
67
Q2 Holdings
QTWO
$3.72B
-11,703
Closed -$335K
TRUP icon
68
Trupanion
TRUP
$1.06B
-46,941
Closed -$793K
SYRS
69
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
-1,388
Closed -$193K
IPHI
70
DELISTED
INPHI CORPORATION
IPHI
-19,785
Closed -$861K
WAGE
71
DELISTED
WageWorks, Inc.
WAGE
-24,195
Closed -$1.47M
CTRL
72
DELISTED
Control4 Corporation
CTRL
-63,006
Closed -$774K
KTWO
73
DELISTED
K2M Group Holdings, Inc
KTWO
-39,498
Closed -$702K
VTAE
74
DELISTED
VITAE PHARMACEUTICALS INC COMMON STOCK
VTAE
-12,636
Closed -$264K
LNKD
75
DELISTED
LinkedIn Corporation
LNKD
-6,806
Closed -$1.3M

Similar funds

Hamilton Lane Advisors's Q4 2016 Portfolio in Review

As of Q4 2016, Hamilton Lane Advisors held 79 positions worth $152M, down 24% from $199M the previous quarter. Its ten largest holdings account for 57% of the portfolio.

Hamilton Lane Advisors withdrew a net $19.6M in Q4 2016, closing 16 positions and reducing 22 holdings. Its most notable exit was CDW, an estimated $4.23M position sold in full.

By sector, the portfolio is most concentrated in Technology at 40% of assets, up from 24% a quarter earlier, followed by Communication Services and Healthcare.

Against the trend, Hamilton Lane Advisors opened a new position in Twilio worth $19.9M.

  • Hamilton Lane Advisors's largest Q4 2016 buy was Twilio: 689,659 shares worth $19.9M.
  • Hamilton Lane Advisors added most to Alphabet (Google) Class A in Q4 2016, an estimated $3.57M increase.
  • Hamilton Lane Advisors's biggest Q4 2016 reduction was Zayo Group Holdings, Inc., cutting an estimated $8.1M.
  • Hamilton Lane Advisors fully exited CDW in Q4 2016, selling an estimated $4.23M.
  • Hamilton Lane Advisors's ten largest holdings make up 57% of its $152M portfolio in Q4 2016.
  • Hamilton Lane Advisors opened 18 new positions and closed 16 in Q4 2016.
  • Hamilton Lane Advisors's portfolio value fell 24% quarter-over-quarter to $152M.

Based on Hamilton Lane Advisors's 13F filing for Q4 2016, filed 26 Jan 2017.